• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . Enhanced CD95 and interleukin 18 signalling accompany T cell receptor Vβ21.3+ activation in multi-inflammatory syndrome in children

tetano

Editor, Senior Moderator
Nat Commun


. 2024 May 18;15(1):4227.
doi: 10.1038/s41467-024-48699-y. Enhanced CD95 and interleukin 18 signalling accompany T cell receptor Vβ21.3+ activation in multi-inflammatory syndrome in children

Zhenguang Zhang[SUP] 1 [/SUP], Iain R L Kean[SUP] 1 [/SUP], Lisa M Dratva[SUP] 2 [/SUP], John A Clark[SUP] 1 [/SUP], Eleni Syrimi[SUP] 3 [/SUP], Naeem Khan[SUP] 3 [/SUP], Esther Daubney[SUP] 4 [/SUP], Deborah White[SUP] 4 [/SUP], Lauran O'Neill[SUP] 5 [/SUP], Catherine Chisholm[SUP] 5 [/SUP], Caroline Payne[SUP] 5 [/SUP], Sarah Benkenstein[SUP] 5 [/SUP], Klaudia Kupiec[SUP] 5 [/SUP], Rachel Galassini[SUP] 6 [/SUP], Victoria Wright[SUP] 6 [/SUP], Helen Winmill[SUP] 7 [/SUP], Ceri Robbins[SUP] 7 [/SUP], Katherine Brown[SUP] 5 [/SUP], Padmanabhan Ramnarayan[SUP] 6 [/SUP], Barnaby Scholefield[SUP] 7 8 [/SUP], Mark Peters[SUP] 5 9 [/SUP], Nigel Klein[SUP] 5 9 [/SUP], Hugh Montgomery[SUP] 10 [/SUP], Kerstin B Meyer[SUP] 2 [/SUP], Sarah A Teichmann[SUP] 2 11 [/SUP], Clare Bryant[SUP] #[/SUP][SUP] 12 [/SUP], Graham Taylor[SUP] #[/SUP][SUP] 13 [/SUP], Nazima Pathan[SUP] #[/SUP][SUP] 14 15 [/SUP]



Affiliations
Abstract

Multisystem inflammatory syndrome in children is a post-infectious presentation SARS-CoV-2 associated with expansion of the T cell receptor Vβ21.3+ T-cell subgroup. Here we apply muti-single cell omics to compare the inflammatory process in children with acute respiratory COVID-19 and those presenting with non SARS-CoV-2 infections in children. Here we show that in Multi-Inflammatory Syndrome in Children (MIS-C), the natural killer cell and monocyte population demonstrate heightened CD95 (Fas) and Interleuking 18 receptor expression. Additionally, TCR Vβ21.3+ CD4+ T-cells exhibit skewed differentiation towards T helper 1, 17 and regulatory T cells, with increased expression of the co-stimulation receptors ICOS, CD28 and interleukin 18 receptor. We observe no functional evidence for NLRP3 inflammasome pathway overactivation, though MIS-C monocytes show elevated active caspase 8. This, coupled with raised IL18 mRNA expression in CD16- NK cells on single cell RNA sequencing analysis, suggests interleukin 18 and CD95 signalling may trigger activation of TCR Vβ21.3+ T-cells in MIS-C, driven by increased IL-18 production from activated monocytes and CD16- Natural Killer cells.


 
Back
Top Bottom